{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T09:28:39Z","timestamp":1793179719721,"version":"4.5.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1127157"],"award-info":[{"award-number":["1127157"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1088215"],"award-info":[{"award-number":["1088215"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s10875-019-00612-9","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T12:04:44Z","timestamp":1553515484000},"page":"148-158","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Immune Dysregulation and Disease Pathogenesis due to Activating Mutations in PIK3CD\u2014the Goldilocks\u2019 Effect"],"prefix":"10.1007","volume":"39","author":[{"given":"Stuart G.","family":"Tangye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Bier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulbu","family":"Uzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa K.","family":"Deenick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,25]]},"reference":[{"key":"612_CR1","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1146\/annurev-immunol-032712-095946","volume":"31","author":"K Okkenhaug","year":"2013","unstructured":"Okkenhaug K. Signaling by the phosphoinositide 3-kinase family in immune cells. Annu Rev Immunol. 2013;31:675\u2013704. \n                    https:\/\/doi.org\/10.1146\/annurev-immunol-032712-095946\n                    \n                  .","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"612_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nri1056","volume":"3","author":"K Okkenhaug","year":"2003","unstructured":"Okkenhaug K, Vanhaesebroeck B. PI3K in lymphocyte development, differentiation and activation. Nat Rev Immunol. 2003;3(4):317\u201330. \n                    https:\/\/doi.org\/10.1038\/nri1056\n                    \n                  .","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"612_CR3","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","volume":"170","author":"DA Fruman","year":"2017","unstructured":"Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT. The PI3K pathway in human disease. Cell. 2017;170(4):605\u201335. \n                    https:\/\/doi.org\/10.1016\/j.cell.2017.07.029\n                    \n                  .","journal-title":"Cell"},{"issue":"4","key":"612_CR4","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.celrep.2013.10.022","volume":"5","author":"J Jellusova","year":"2013","unstructured":"Jellusova J, Miletic AV, Cato MH, Lin WW, Hu Y, Bishop GA, et al. Context-specific BAFF-R signaling by the NF-kappaB and PI3K pathways. Cell Rep. 2013;5(4):1022\u201335. \n                    https:\/\/doi.org\/10.1016\/j.celrep.2013.10.022\n                    \n                  .","journal-title":"Cell Rep"},{"key":"612_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00228","volume":"3","author":"JJ Limon","year":"2012","unstructured":"Limon JJ, Fruman DA. Akt and mTOR in B cell activation and differentiation. Front Immunol. 2012;3:228. \n                    https:\/\/doi.org\/10.3389\/fimmu.2012.00228\n                    \n                  .","journal-title":"Front Immunol"},{"issue":"1","key":"612_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1600-065X.2009.00764.x","volume":"229","author":"PF Yong","year":"2009","unstructured":"Yong PF, Salzer U, Grimbacher B. The role of costimulation in antibody deficiencies: ICOS and common variable immunodeficiency. Immunol Rev. 2009;229(1):101\u201313. \n                    https:\/\/doi.org\/10.1111\/j.1600-065X.2009.00764.x\n                    \n                  .","journal-title":"Immunol Rev"},{"issue":"48","key":"612_CR7","doi-asserted-by":"publisher","first-page":"20371","DOI":"10.1073\/pnas.0911573106","volume":"106","author":"M Gigoux","year":"2009","unstructured":"Gigoux M, Shang J, Pak Y, Xu M, Choe J, Mak TW, et al. Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase. Proc Natl Acad Sci U S A. 2009;106(48):20371\u20136. \n                    https:\/\/doi.org\/10.1073\/pnas.0911573106\n                    \n                  .","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"612_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1189\/jlb.0806494","volume":"82","author":"V Ostiguy","year":"2007","unstructured":"Ostiguy V, Allard EL, Marquis M, Leignadier J, Labrecque N. IL-21 promotes T lymphocyte survival by activating the phosphatidylinositol-3 kinase signaling cascade. J Leukoc Biol. 2007;82(3):645\u201356. \n                    https:\/\/doi.org\/10.1189\/jlb.0806494\n                    \n                  .","journal-title":"J Leukoc Biol"},{"issue":"5400","key":"612_CR9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1126\/science.283.5400.393","volume":"283","author":"DA Fruman","year":"1999","unstructured":"Fruman DA, Snapper SB, Yballe CM, Davidson L, Yu JY, Alt FW, et al. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. Science. 1999;283(5400):393\u20137.","journal-title":"Science"},{"issue":"5400","key":"612_CR10","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1126\/science.283.5400.390","volume":"283","author":"H Suzuki","year":"1999","unstructured":"Suzuki H, Terauchi Y, Fujiwara M, Aizawa S, Yazaki Y, Kadowaki T, et al. Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. Science. 1999;283(5400):390\u20132.","journal-title":"Science"},{"issue":"6","key":"612_CR11","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1084\/jem.20020805","volume":"196","author":"E Clayton","year":"2002","unstructured":"Clayton E, Bardi G, Bell SE, Chantry D, Downes CP, Gray A, et al. A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation. J Exp Med. 2002;196(6):753\u201363.","journal-title":"J Exp Med"},{"issue":"5583","key":"612_CR12","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1126\/science.1073560","volume":"297","author":"K Okkenhaug","year":"2002","unstructured":"Okkenhaug K, Bilancio A, Farjot G, Priddle H, Sancho S, Peskett E, et al. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science. 2002;297(5583):1031\u20134. \n                    https:\/\/doi.org\/10.1126\/science.1073560\n                    \n                  .","journal-title":"Science."},{"issue":"24","key":"612_CR13","doi-asserted-by":"publisher","first-page":"8580","DOI":"10.1128\/MCB.22.24.8580-8591.2002","volume":"22","author":"ST Jou","year":"2002","unstructured":"Jou ST, Carpino N, Takahashi Y, Piekorz R, Chao JR, Carpino N, et al. Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex. Mol Cell Biol. 2002;22(24):8580\u201391.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"612_CR14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.cell.2009.08.041","volume":"139","author":"L Srinivasan","year":"2009","unstructured":"Srinivasan L, Sasaki Y, Calado DP, Zhang B, Paik JH, DePinho RA, et al. PI3 kinase signals BCR-dependent mature B cell survival. Cell. 2009;139(3):573\u201386. \n                    https:\/\/doi.org\/10.1016\/j.cell.2009.08.041\n                    \n                  .","journal-title":"Cell"},{"issue":"3","key":"612_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/ni892","volume":"4","author":"AN Anzelon","year":"2003","unstructured":"Anzelon AN, Wu H, Rickert RC. Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat Immunol. 2003;4(3):287\u201394. \n                    https:\/\/doi.org\/10.1038\/ni892\n                    \n                  .","journal-title":"Nat Immunol"},{"issue":"5","key":"612_CR16","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1084\/jem.20021101","volume":"197","author":"A Suzuki","year":"2003","unstructured":"Suzuki A, Kaisho T, Ohishi M, Tsukio-Yamaguchi M, Tsubata T, Koni PA, et al. Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination. J Exp Med. 2003;197(5):657\u201367.","journal-title":"J Exp Med"},{"issue":"6","key":"612_CR17","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.immuni.2015.10.021","volume":"43","author":"S Sander","year":"2015","unstructured":"Sander S, Chu VT, Yasuda T, Franklin A, Graf R, Calado DP, et al. PI3 kinase and FOXO1 transcription factor activity differentially control B cells in the germinal center light and dark zones. Immunity. 2015;43(6):1075\u201386. \n                    https:\/\/doi.org\/10.1016\/j.immuni.2015.10.021\n                    \n                  .","journal-title":"Immunity"},{"issue":"6","key":"612_CR18","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.immuni.2015.10.015","volume":"43","author":"D Dominguez-Sola","year":"2015","unstructured":"Dominguez-Sola D, Kung J, Holmes AB, Wells VA, Mo T, Basso K, et al. The FOXO1 transcription factor instructs the germinal center dark zone program. Immunity. 2015;43(6):1064\u201374. \n                    https:\/\/doi.org\/10.1016\/j.immuni.2015.10.015\n                    \n                  .","journal-title":"Immunity"},{"issue":"4","key":"612_CR19","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.immuni.2006.08.015","volume":"25","author":"SA Omori","year":"2006","unstructured":"Omori SA, Cato MH, Anzelon-Mills A, Puri KD, Shapiro-Shelef M, Calame K, et al. Regulation of class-switch recombination and plasma cell differentiation by phosphatidylinositol 3-kinase signaling. Immunity. 2006;25(4):545\u201357. \n                    https:\/\/doi.org\/10.1016\/j.immuni.2006.08.015\n                    \n                  .","journal-title":"Immunity"},{"issue":"12","key":"612_CR20","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1038\/ni.1667","volume":"9","author":"HS Dengler","year":"2008","unstructured":"Dengler HS, Baracho GV, Omori SA, Bruckner S, Arden KC, Castrillon DH, et al. Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation. Nat Immunol. 2008;9(12):1388\u201398. \n                    https:\/\/doi.org\/10.1038\/ni.1667\n                    \n                  .","journal-title":"Nat Immunol"},{"issue":"5","key":"612_CR21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S1074-7613(01)00134-0","volume":"14","author":"A Suzuki","year":"2001","unstructured":"Suzuki A, Yamaguchi MT, Ohteki T, Sasaki T, Kaisho T, Kimura Y, et al. T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity. 2001;14(5):523\u201334.","journal-title":"Immunity"},{"issue":"8","key":"612_CR22","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.4049\/jimmunol.177.8.5122","volume":"177","author":"K Okkenhaug","year":"2006","unstructured":"Okkenhaug K, Patton DT, Bilancio A, Garcon F, Rowan WC, Vanhaesebroeck B. The p110delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells. J Immunol. 2006;177(8):5122\u20138.","journal-title":"J Immunol"},{"issue":"11","key":"612_CR23","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1182\/blood-2009-07-232330","volume":"115","author":"DR Soond","year":"2010","unstructured":"Soond DR, Bjorgo E, Moltu K, Dale VQ, Patton DT, Torgersen KM, et al. PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans. Blood. 2010;115(11):2203\u201313. \n                    https:\/\/doi.org\/10.1182\/blood-2009-07-232330\n                    \n                  .","journal-title":"Blood"},{"issue":"7","key":"612_CR24","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.4049\/jimmunol.1001730","volume":"185","author":"J Rolf","year":"2010","unstructured":"Rolf J, Bell SE, Kovesdi D, Janas ML, Soond DR, Webb LM, et al. Phosphoinositide 3-kinase activity in T cells regulates the magnitude of the germinal center reaction. J Immunol. 2010;185(7):4042\u201352. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1001730\n                    \n                  .","journal-title":"J Immunol"},{"issue":"6","key":"612_CR25","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/gene.2008.45","volume":"9","author":"A Awasthi","year":"2008","unstructured":"Awasthi A, Samarakoon A, Dai X, Wen R, Wang D, Malarkannan S. Deletion of PI3K-p85alpha gene impairs lineage commitment, terminal maturation, cytokine generation and cytotoxicity of NK cells. Genes Immun. 2008;9(6):522\u201335. \n                    https:\/\/doi.org\/10.1038\/gene.2008.45\n                    \n                  .","journal-title":"Genes Immun"},{"issue":"10","key":"612_CR26","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1084\/jem.20072327","volume":"205","author":"H Guo","year":"2008","unstructured":"Guo H, Samarakoon A, Vanhaesebroeck B, Malarkannan S. The p110 delta of PI3K plays a critical role in NK cell terminal maturation and cytokine\/chemokine generation. J Exp Med. 2008;205(10):2419\u201335. \n                    https:\/\/doi.org\/10.1084\/jem.20072327\n                    \n                  .","journal-title":"J Exp Med"},{"issue":"3","key":"612_CR27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1084\/jem.20112533","volume":"209","author":"ME Conley","year":"2012","unstructured":"Conley ME, Dobbs AK, Quintana AM, Bosompem A, Wang YD, Coustan-Smith E, et al. Agammaglobulinemia and absent B lineage cells in a patient lacking the p85alpha subunit of PI3K. J Exp Med. 2012;209(3):463\u201370. \n                    https:\/\/doi.org\/10.1084\/jem.20112533\n                    \n                  .","journal-title":"J Exp Med"},{"issue":"3","key":"612_CR28","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s10875-014-0012-9","volume":"34","author":"MC Crank","year":"2014","unstructured":"Crank MC, Grossman JK, Moir S, Pittaluga S, Buckner CM, Kardava L, et al. Mutations in PIK3CD can cause hyper IgM syndrome (HIGM) associated with increased cancer susceptibility. J Clin Immunol. 2014;34(3):272\u20136. \n                    https:\/\/doi.org\/10.1007\/s10875-014-0012-9\n                    \n                  .","journal-title":"J Clin Immunol"},{"issue":"2","key":"612_CR29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/cei.12706","volume":"183","author":"M Elgizouli","year":"2016","unstructured":"Elgizouli M, Lowe DM, Speckmann C, Schubert D, Hulsdunker J, Eskandarian Z, et al. Activating PI3Kdelta mutations in a cohort of 669 patients with primary immunodeficiency. Clin Exp Immunol. 2016;183(2):221\u20139. \n                    https:\/\/doi.org\/10.1111\/cei.12706\n                    \n                  .","journal-title":"Clin Exp Immunol"},{"key":"612_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10875-014-0109-1","volume":"35","author":"HN Hartman","year":"2014","unstructured":"Hartman HN, Niemela J, Hintermeyer MK, Garofalo M, Stoddard J, Verbsky JW, et al. Gain of function mutations of PIK3CD as a cause of primary Sclerosing cholangitis. J Clin Immunol. 2014;35:11\u20134. \n                    https:\/\/doi.org\/10.1007\/s10875-014-0109-1\n                    \n                  .","journal-title":"J Clin Immunol"},{"key":"612_CR31","doi-asserted-by":"publisher","unstructured":"Bier J, Rao G, Payne K, Brigden H, French E, Pelham SJ, et al. Activating mutations in PIK3CD disrupt the differentiation and function of human and murine CD4(+) T cells. J Allergy Clin Immunol. 2019. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2019.01.033\n                    \n                  .","DOI":"10.1016\/j.jaci.2019.01.033"},{"issue":"2","key":"612_CR32","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","volume":"139","author":"TI Coulter","year":"2017","unstructured":"Coulter TI, Chandra A, Bacon CM, Babar J, Curtis J, Screaton N, et al. Clinical spectrum and features of activated phosphoinositide 3-kinase delta syndrome: a large patient cohort study. J Allergy Clin Immunol. 2017;139(2):597\u2013606 e4. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2016.06.021\n                    \n                  .","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"612_CR33","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jaci.2018.04.030","volume":"143","author":"ESJ Edwards","year":"2019","unstructured":"Edwards ESJ, Bier J, Cole TS, Wong M, Hsu P, Berglund LJ, et al. Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity. J Allergy Clin Immunol. 2019;143(1):276\u201391 e6. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2018.04.030\n                    \n                  .","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"612_CR34","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jaci.2014.02.020","volume":"134","author":"S Kracker","year":"2014","unstructured":"Kracker S, Curtis J, Ibrahim MA, Sediva A, Salisbury J, Campr V, et al. Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase delta syndrome. J Allergy Clin Immunol. 2014;134(1):233\u20136. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2014.02.020\n                    \n                  .","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"612_CR35","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10875-017-0393-7","volume":"37","author":"F Goto","year":"2017","unstructured":"Goto F, Uchiyama T, Nakazawa Y, Imai K, Kawai T, Onodera M. Persistent impairment of T-cell regeneration in a patient with activated PI3K delta syndrome. J Clin Immunol. 2017;37(4):347\u201350. \n                    https:\/\/doi.org\/10.1007\/s10875-017-0393-7\n                    \n                  .","journal-title":"J Clin Immunol"},{"key":"612_CR36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.clim.2017.01.004","volume":"176","author":"M Wentink","year":"2017","unstructured":"Wentink M, Dalm V, Lankester AC, van Schouwenburg PA, Scholvinck L, Kalina T, et al. Genetic defects in PI3Kdelta affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections. Clin Immunol. 2017;176:77\u201386. \n                    https:\/\/doi.org\/10.1016\/j.clim.2017.01.004\n                    \n                  .","journal-title":"Clin Immunol"},{"key":"612_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00446","volume":"9","author":"MWJ Wentink","year":"2018","unstructured":"Wentink MWJ, Mueller YM, Dalm V, Driessen GJ, van Hagen PM, van Montfrans JM, et al. Exhaustion of the CD8(+) T cell compartment in patients with mutations in phosphoinositide 3-Kinase Delta. Front Immunol. 2018;9:446. \n                    https:\/\/doi.org\/10.3389\/fimmu.2018.00446\n                    \n                  .","journal-title":"Front Immunol"},{"key":"612_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00543","volume":"9","author":"ME Maccari","year":"2018","unstructured":"Maccari ME, Abolhassani H, Aghamohammadi A, Aiuti A, Aleinikova O, Bangs C, et al. Disease evolution and response to rapamycin in activated phosphoinositide 3-kinase delta syndrome: the European Society for Immunodeficiencies-Activated Phosphoinositide 3-kinase delta syndrome registry. Front Immunol. 2018;9:543. \n                    https:\/\/doi.org\/10.3389\/fimmu.2018.00543\n                    \n                  .","journal-title":"Front Immunol"},{"issue":"6","key":"612_CR39","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/j.jaci.2016.03.055","volume":"138","author":"Y Tsujita","year":"2016","unstructured":"Tsujita Y, Mitsui-Sekinaka K, Imai K, Yeh TW, Mitsuiki N, Asano T, et al. Phosphatase and tensin homolog (PTEN) mutation can cause activated phosphatidylinositol 3-kinase delta syndrome-like immunodeficiency. J Allergy Clin Immunol. 2016;138(6):1672\u201380 e10. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2016.03.055\n                    \n                  .","journal-title":"J Allergy Clin Immunol"},{"key":"612_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00369","volume":"9","author":"D Michalovich","year":"2018","unstructured":"Michalovich D, Nejentsev S. Activated PI3 Kinase Delta syndrome: from genetics to therapy. Front Immunol. 2018;9:369. \n                    https:\/\/doi.org\/10.3389\/fimmu.2018.00369\n                    \n                  .","journal-title":"Front Immunol"},{"issue":"3","key":"612_CR41","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jaci.2016.08.028","volume":"139","author":"AE Dulau Florea","year":"2017","unstructured":"Dulau Florea AE, Braylan RC, Schafernak KT, Williams KW, Daub J, Goyal RK, et al. Abnormal B-cell maturation in the bone marrow of patients with germline mutations in PIK3CD. J Allergy Clin Immunol. 2017;139(3):1032\u20135 e6. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2016.08.028\n                    \n                  .","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"612_CR42","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.jaci.2016.09.040","volume":"139","author":"Z Nademi","year":"2017","unstructured":"Nademi Z, Slatter MA, Dvorak CC, Neven B, Fischer A, Suarez F, et al. Hematopoietic stem cell transplant in patients with activated PI3K delta syndrome. J Allergy Clin Immunol. 2017;139(3):1046\u20139. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2016.09.040\n                    \n                  .","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"612_CR43","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jaci.2018.04.032","volume":"143","author":"T Okano","year":"2019","unstructured":"Okano T, Imai K, Tsujita Y, Mitsuiki N, Yoshida K, Kamae C, et al. Hematopoietic stem cell transplantation for progressive combined immunodeficiency and lymphoproliferation in patients with activated phosphatidylinositol-3-OH kinase delta syndrome type 1. J Allergy Clin Immunol. 2019;143(1):266\u201375. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2018.04.032\n                    \n                  .","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"612_CR44","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1172\/JCI75746","volume":"124","author":"MC Deau","year":"2014","unstructured":"Deau MC, Heurtier L, Frange P, Suarez F, Bole-Feysot C, Nitschke P, et al. A human immunodeficiency caused by mutations in the PIK3R1 gene. J Clin Invest. 2014;124(9):3923\u20138. \n                    https:\/\/doi.org\/10.1172\/JCI75746\n                    \n                  .","journal-title":"J Clin Invest"},{"issue":"13","key":"612_CR45","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1084\/jem.20141759","volume":"211","author":"CL Lucas","year":"2014","unstructured":"Lucas CL, Zhang Y, Venida A, Wang Y, Hughes J, McElwee J, et al. Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K. J Exp Med. 2014;211(13):2537\u201347. \n                    https:\/\/doi.org\/10.1084\/jem.20141759\n                    \n                  .","journal-title":"J Exp Med"},{"issue":"1","key":"612_CR46","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jaci.2016.03.022","volume":"138","author":"E Elkaim","year":"2016","unstructured":"Elkaim E, Neven B, Bruneau J, Mitsui-Sekinaka K, Stanislas A, Heurtier L, et al. Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase delta syndrome 2: a cohort study. J Allergy Clin Immunol. 2016;138(1):210\u20138 e9. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2016.03.022\n                    \n                  .","journal-title":"J Allergy Clin Immunol"},{"key":"612_CR47","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.clim.2017.03.004","volume":"179","author":"M Bravo Garcia-Morato","year":"2017","unstructured":"Bravo Garcia-Morato M, Garcia-Minaur S, Molina Garicano J, Santos Simarro F, Del Pino Molina L, Lopez-Granados E, et al. Mutations in PIK3R1 can lead to APDS2, SHORT syndrome or a combination of the two. Clin Immunol. 2017;179:77\u201380. \n                    https:\/\/doi.org\/10.1016\/j.clim.2017.03.004\n                    \n                  .","journal-title":"Clin Immunol"},{"key":"612_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.clim.2015.10.008","volume":"162","author":"M Kuhlen","year":"2016","unstructured":"Kuhlen M, Honscheid A, Loizou L, Nabhani S, Fischer U, Stepensky P, et al. De novo PIK3R1 gain-of-function with recurrent sinopulmonary infections, long-lasting chronic CMV-lymphadenitis and microcephaly. Clin Immunol. 2016;162:27\u201330. \n                    https:\/\/doi.org\/10.1016\/j.clim.2015.10.008\n                    \n                  .","journal-title":"Clin Immunol"},{"issue":"5","key":"612_CR49","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s10875-016-0281-6","volume":"36","author":"S Petrovski","year":"2016","unstructured":"Petrovski S, Parrott RE, Roberts JL, Huang H, Yang J, Gorentla B, et al. Dominant splice site mutations in PIK3R1 cause hyper IgM syndrome, lymphadenopathy and short stature. J Clin Immunol. 2016;36(5):462\u201371. \n                    https:\/\/doi.org\/10.1007\/s10875-016-0281-6\n                    \n                  .","journal-title":"J Clin Immunol"},{"issue":"1","key":"612_CR50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.clim.2015.04.014","volume":"159","author":"V Lougaris","year":"2015","unstructured":"Lougaris V, Faletra F, Lanzi G, Vozzi D, Marcuzzi A, Valencic E, et al. Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype. Clin Immunol. 2015;159(1):33\u20136. \n                    https:\/\/doi.org\/10.1016\/j.clim.2015.04.014\n                    \n                  .","journal-title":"Clin Immunol"},{"issue":"6","key":"612_CR51","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/pai.12585","volume":"27","author":"P Olbrich","year":"2016","unstructured":"Olbrich P, Lorenz M, Cura Daball P, Lucena JM, Rensing-Ehl A, Sanchez B, et al. Activated PI3Kdelta syndrome type 2: two patients, a novel mutation, and review of the literature. Pediatr Allergy Immunol. 2016;27(6):640\u20134. \n                    https:\/\/doi.org\/10.1111\/pai.12585\n                    \n                  .","journal-title":"Pediatr Allergy Immunol"},{"key":"612_CR52","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.clim.2016.09.011","volume":"173","author":"MT Martinez-Saavedra","year":"2016","unstructured":"Martinez-Saavedra MT, Garcia-Gomez S, Dominguez Acosta A, Mendoza Quintana JJ, Paez JP, Garcia-Reino EJ, et al. Gain-of-function mutation in PIK3R1 in a patient with a narrow clinical phenotype of respiratory infections. Clin Immunol. 2016;173:117\u201320. \n                    https:\/\/doi.org\/10.1016\/j.clim.2016.09.011\n                    \n                  .","journal-title":"Clin Immunol"},{"issue":"12","key":"612_CR53","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/jmedgenet-2015-103266","volume":"52","author":"MJ Browning","year":"2015","unstructured":"Browning MJ, Chandra A, Carbonaro V, Okkenhaug K, Barwell J. Cowden\u2019s syndrome with immunodeficiency. J Med Genet. 2015;52(12):856\u20139. \n                    https:\/\/doi.org\/10.1136\/jmedgenet-2015-103266\n                    \n                  .","journal-title":"J Med Genet"},{"issue":"6","key":"612_CR54","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.jaci.2016.07.010","volume":"138","author":"GJ Driessen","year":"2016","unstructured":"Driessen GJ, H IJ, Wentink M, Yntema HG, van Hagen PM, van Strien A, et al. Increased PI3K\/Akt activity and deregulated humoral immune response in human PTEN deficiency. J Allergy Clin Immunol. 2016;138(6):1744\u20137 e5. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2016.07.010\n                    \n                  .","journal-title":"J Allergy Clin Immunol"},{"key":"612_CR55","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s10875-017-0462-y","volume":"38","author":"P Tang","year":"2017","unstructured":"Tang P, Upton JEM, Barton-Forbes MA, Salvadori MI, Clynick MP, Price AK, et al. Autosomal recessive Agammaglobulinemia due to a homozygous mutation in PIK3R1. J Clin Immunol. 2017;38:88\u201395. \n                    https:\/\/doi.org\/10.1007\/s10875-017-0462-y\n                    \n                  .","journal-title":"J Clin Immunol"},{"issue":"6160","key":"612_CR56","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1126\/science.1243292","volume":"342","author":"I Angulo","year":"2013","unstructured":"Angulo I, Vadas O, Garcon F, Banham-Hall E, Plagnol V, Leahy TR, et al. Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage. Science. 2013;342(6160):866\u201371. \n                    https:\/\/doi.org\/10.1126\/science.1243292\n                    \n                  .","journal-title":"Science"},{"issue":"1","key":"612_CR57","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ni.2771","volume":"15","author":"CL Lucas","year":"2014","unstructured":"Lucas CL, Kuehn HS, Zhao F, Niemela JE, Deenick EK, Palendira U, et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110delta result in T cell senescence and human immunodeficiency. Nat Immunol. 2014;15(1):88\u201397. \n                    https:\/\/doi.org\/10.1038\/ni.2771\n                    \n                  .","journal-title":"Nat Immunol"},{"issue":"4","key":"612_CR58","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.jaci.2017.03.026","volume":"140","author":"AJ Takeda","year":"2017","unstructured":"Takeda AJ, Zhang Y, Dornan GL, Siempelkamp BD, Jenkins ML, Matthews HF, et al. Novel PIK3CD mutations affecting N-terminal residues of p110delta cause activated PI3Kdelta syndrome (APDS) in humans. J Allergy Clin Immunol. 2017;140(4):1152\u20136 e10. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2017.03.026\n                    \n                  .","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"612_CR59","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1073\/pnas.1617244114","volume":"114","author":"GL Dornan","year":"2017","unstructured":"Dornan GL, Siempelkamp BD, Jenkins ML, Vadas O, Lucas CL, Burke JE. Conformational disruption of PI3Kdelta regulation by immunodeficiency mutations in PIK3CD and PIK3R1. Proc Natl Acad Sci U S A. 2017;114(8):1982\u20137. \n                    https:\/\/doi.org\/10.1073\/pnas.1617244114\n                    \n                  .","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"612_CR60","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1744-313X.2006.00627.x","volume":"33","author":"ST Jou","year":"2006","unstructured":"Jou ST, Chien YH, Yang YH, Wang TC, Shyur SD, Chou CC, et al. Identification of variations in the human phosphoinositide 3-kinase p110delta gene in children with primary B-cell immunodeficiency of unknown aetiology. Int J Immunogenet. 2006;33(5):361\u20139. \n                    https:\/\/doi.org\/10.1111\/j.1744-313X.2006.00627.x\n                    \n                  .","journal-title":"Int J Immunogenet"},{"key":"612_CR61","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.clim.2016.07.017","volume":"171","author":"W Rae","year":"2016","unstructured":"Rae W, Ramakrishnan KA, Gao Y, Ashton-Key M, Pengelly RJ, Patel SV, et al. Precision treatment with sirolimus in a case of activated phosphoinositide 3-kinase delta syndrome. Clin Immunol. 2016;171:38\u201340. \n                    https:\/\/doi.org\/10.1016\/j.clim.2016.07.017\n                    \n                  .","journal-title":"Clin Immunol"},{"key":"612_CR62","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1182\/blood-2017-08-801191.","volume":"130","author":"VK Rao","year":"2017","unstructured":"Rao VK, Webster S, Dalm V, Sediva A, van Hagen PM, Holland S, et al. Effective 'Activated PI3Kdelta Syndrome'-targeted therapy with the PI3Kdelta inhibitor leniolisib. Blood. 2017;130:2307\u201316. \n                    https:\/\/doi.org\/10.1182\/blood-2017-08-801191.","journal-title":"Blood"},{"issue":"8","key":"612_CR63","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1084\/jem.20180010","volume":"215","author":"DT Avery","year":"2018","unstructured":"Avery DT, Kane A, Nguyen T, Lau A, Nguyen A, Lenthall H, et al. Germline-activating mutations in PIK3CD compromise B cell development and function. J Exp Med. 2018;215(8):2073\u201395. \n                    https:\/\/doi.org\/10.1084\/jem.20180010\n                    \n                  .","journal-title":"J Exp Med"},{"issue":"9","key":"612_CR64","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/s41590-018-0182-3","volume":"19","author":"S Preite","year":"2018","unstructured":"Preite S, Cannons JL, Radtke AJ, Vujkovic-Cvijin I, Gomez-Rodriguez J, Volpi S, et al. Hyperactivated PI3Kdelta promotes self and commensal reactivity at the expense of optimal humoral immunity. Nat Immunol. 2018;19(9):986\u20131000. \n                    https:\/\/doi.org\/10.1038\/s41590-018-0182-3\n                    \n                  .","journal-title":"Nat Immunol"},{"issue":"4","key":"612_CR65","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jaci.2015.05.036","volume":"136","author":"CS Ma","year":"2015","unstructured":"Ma CS, Wong N, Rao G, Avery DT, Torpy J, Hambridge T, et al. Monogenic mutations differentially affect the quantity and quality of T follicular helper cells in patients with human primary immunodeficiencies. J Allergy Clin Immunol. 2015;136(4):993\u20131006 e1. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2015.05.036\n                    \n                  .","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"612_CR66","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.immuni.2010.12.012","volume":"34","author":"R Morita","year":"2011","unstructured":"Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G, et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity. 2011;34(1):108\u201321. \n                    https:\/\/doi.org\/10.1016\/j.immuni.2010.12.012\n                    \n                  .","journal-title":"Immunity"},{"issue":"2","key":"612_CR67","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jaci.2017.04.041","volume":"141","author":"S Unger","year":"2018","unstructured":"Unger S, Seidl M, van Schouwenburg P, Rakhmanov M, Bulashevska A, Frede N, et al. The TH1 phenotype of follicular helper T cells indicates an IFN-gamma-associated immune dysregulation in patients with CD21low common variable immunodeficiency. J Allergy Clin Immunol. 2018;141(2):730\u201340. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2017.04.041\n                    \n                  .","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"612_CR68","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.jaci.2008.08.008","volume":"122","author":"TT Zhang","year":"2008","unstructured":"Zhang TT, Okkenhaug K, Nashed BF, Puri KD, Knight ZA, Shokat KM, et al. Genetic or pharmaceutical blockade of p110delta phosphoinositide 3-kinase enhances IgE production. J Allergy Clin Immunol. 2008;122(4):811\u20139 e2. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2008.08.008\n                    \n                  .","journal-title":"J Allergy Clin Immunol"},{"key":"612_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01758","volume":"9","author":"JL Cannons","year":"2018","unstructured":"Cannons JL, Preite S, Kapnick SM, Uzel G, Schwartzberg PL. Genetic defects in phosphoinositide 3-kinase delta influence CD8(+) T cell survival, differentiation, and function. Front Immunol. 2018;9:1758. \n                    https:\/\/doi.org\/10.3389\/fimmu.2018.01758\n                    \n                  .","journal-title":"Front Immunol"},{"issue":"11","key":"612_CR70","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nri3307","volume":"12","author":"SM Kaech","year":"2012","unstructured":"Kaech SM, Cui W. Transcriptional control of effector and memory CD8+ T cell differentiation. Nat Rev Immunol. 2012;12(11):749\u201361. \n                    https:\/\/doi.org\/10.1038\/nri3307\n                    \n                  .","journal-title":"Nat Rev Immunol"},{"key":"612_CR71","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.jaci.2017.11.042","volume":"142","author":"R Ruiz-Garcia","year":"2018","unstructured":"Ruiz-Garcia R, Vargas-Hernandez A, Chinn IK, Angelo LS, Cao TN, Coban-Akdemir Z, et al. Mutations in PI3K110delta cause impaired natural killer cell function partially rescued by rapamycin treatment. J Allergy Clin Immunol. 2018;142:605\u2013617.e7. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2017.11.042\n                    \n                  .","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"612_CR72","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.immuni.2009.08.026","volume":"31","author":"CD Browne","year":"2009","unstructured":"Browne CD, Del Nagro CJ, Cato MH, Dengler HS, Rickert RC. Suppression of phosphatidylinositol 3,4,5-trisphosphate production is a key determinant of B cell anergy. Immunity. 2009;31(5):749\u201360. \n                    https:\/\/doi.org\/10.1016\/j.immuni.2009.08.026\n                    \n                  .","journal-title":"Immunity"},{"issue":"11","key":"612_CR73","doi-asserted-by":"publisher","first-page":"5461","DOI":"10.4049\/jimmunol.1501375","volume":"195","author":"Z Chen","year":"2015","unstructured":"Chen Z, Getahun A, Chen X, Dollin Y, Cambier JC, Wang JH. Imbalanced PTEN and PI3K signaling impairs class switch recombination. J Immunol. 2015;195(11):5461\u201371. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1501375\n                    \n                  .","journal-title":"J Immunol"},{"issue":"11","key":"612_CR74","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1084\/jem.20091962","volume":"207","author":"AV Miletic","year":"2010","unstructured":"Miletic AV, Anzelon-Mills AN, Mills DM, Omori SA, Pedersen IM, Shin DM, et al. Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases. J Exp Med. 2010;207(11):2407\u201320. \n                    https:\/\/doi.org\/10.1084\/jem.20091962\n                    \n                  .","journal-title":"J Exp Med"},{"issue":"1","key":"612_CR75","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1038\/s41467-018-05674-8","volume":"9","author":"AK Stark","year":"2018","unstructured":"Stark AK, Chandra A, Chakraborty K, Alam R, Carbonaro V, Clark J, et al. PI3Kdelta hyper-activation promotes development of B cells that exacerbate Streptococcus pneumoniae infection in an antibody-independent manner. Nat Commun. 2018;9(1):3174. \n                    https:\/\/doi.org\/10.1038\/s41467-018-05674-8\n                    \n                  .","journal-title":"Nat Commun"},{"issue":"10","key":"612_CR76","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1084\/jem.20180617","volume":"215","author":"MN Wray-Dutra","year":"2018","unstructured":"Wray-Dutra MN, Al Qureshah F, Metzler G, Oukka M, James RG, Rawlings DJ. Activated PIK3CD drives innate B cell expansion yet limits B cell-intrinsic immune responses. J Exp Med. 2018;215(10):2485\u201396. \n                    https:\/\/doi.org\/10.1084\/jem.20180617\n                    \n                  .","journal-title":"J Exp Med"},{"key":"612_CR77","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.3389\/fimmu.2018.03079","volume":"9","author":"S Preite","year":"2018","unstructured":"Preite S, Huang B, Cannons JL, McGavern DB, Schwartzberg PL. PI3K orchestrates T follicular helper cell differentiation in a context dependent manner: implications for autoimmunity. Front Immunol. 2018;9:3079. \n                    https:\/\/doi.org\/10.3389\/fimmu.2018.03079\n                    \n                  .","journal-title":"Front Immunol"},{"issue":"1","key":"612_CR78","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ajhg.2013.05.023","volume":"93","author":"KK Chudasama","year":"2013","unstructured":"Chudasama KK, Winnay J, Johansson S, Claudi T, Konig R, Haldorsen I, et al. SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling. Am J Hum Genet. 2013;93(1):150\u20137. \n                    https:\/\/doi.org\/10.1016\/j.ajhg.2013.05.023\n                    \n                  .","journal-title":"Am J Hum Genet"},{"issue":"1","key":"612_CR79","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ajhg.2013.06.005","volume":"93","author":"DA Dyment","year":"2013","unstructured":"Dyment DA, Smith AC, Alcantara D, Schwartzentruber JA, Basel-Vanagaite L, Curry CJ, et al. Mutations in PIK3R1 cause SHORT syndrome. Am J Hum Genet. 2013;93(1):158\u201366. \n                    https:\/\/doi.org\/10.1016\/j.ajhg.2013.06.005\n                    \n                  .","journal-title":"Am J Hum Genet"},{"issue":"1","key":"612_CR80","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ajhg.2013.05.019","volume":"93","author":"C Thauvin-Robinet","year":"2013","unstructured":"Thauvin-Robinet C, Auclair M, Duplomb L, Caron-Debarle M, Avila M, St-Onge J, et al. PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy. Am J Hum Genet. 2013;93(1):141\u20139. \n                    https:\/\/doi.org\/10.1016\/j.ajhg.2013.05.019\n                    \n                  .","journal-title":"Am J Hum Genet"},{"issue":"3","key":"612_CR81","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/hmg\/7.3.507","volume":"7","author":"DJ Marsh","year":"1998","unstructured":"Marsh DJ, Coulon V, Lunetta KL, Rocca-Serra P, Dahia PL, Zheng Z, et al. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet. 1998;7(3):507\u201315.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"612_CR82","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jaci.2016.03.059","volume":"139","author":"HH Chen","year":"2017","unstructured":"Chen HH, Handel N, Ngeow J, Muller J, Huhn M, Yang HT, et al. Immune dysregulation in patients with PTEN hamartoma tumor syndrome: analysis of FOXP3 regulatory T cells. J Allergy Clin Immunol. 2017;139(2):607\u201320 e15. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2016.03.059\n                    \n                  .","journal-title":"J Allergy Clin Immunol"},{"key":"612_CR83","first-page":"673","volume":"33","author":"K Zhang","year":"2013","unstructured":"Zhang K, Husami A, Marsh R, Jordan MB. Identification of a phosphoinositide 3-kinase (PI-3K) p110 delta (PIK3CD) deficent individual. J Clin Immunol. 2013;33:673\u20134.","journal-title":"J Clin Immunol"},{"issue":"5","key":"612_CR84","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.jaci.2018.06.039","volume":"142","author":"G Sogkas","year":"2018","unstructured":"Sogkas G, Fedchenko M, Dhingra A, Jablonka A, Schmidt RE, Atschekzei F. Primary immunodeficiency disorder caused by phosphoinositide 3-kinase delta deficiency. J Allergy Clin Immunol. 2018;142(5):1650\u20133 e2. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2018.06.039\n                    \n                  .","journal-title":"J Allergy Clin Immunol"},{"key":"612_CR85","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.jaci.2018.10.005","volume":"143","author":"SB Cohen","year":"2018","unstructured":"Cohen SB, Bainter W, Johnson JL, Lin TY, Wong JCY, Wallace JG, et al. Human primary immunodeficiency caused by expression of a kinase-dead p110delta mutant. J Allergy Clin Immunol. 2018;143:797\u2013799.e2. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2018.10.005\n                    \n                  .","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"612_CR86","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jaci.2017.10.033","volume":"142","author":"N Sharfe","year":"2018","unstructured":"Sharfe N, Karanxha A, Dadi H, Merico D, Chitayat D, Herbrick JA, et al. Dual loss of p110delta PI3-kinase and SKAP (KNSTRN) expression leads to combined immunodeficiency and multisystem syndromic features. J Allergy Clin Immunol. 2018;142(2):618\u201329. \n                    https:\/\/doi.org\/10.1016\/j.jaci.2017.10.033\n                    \n                  .","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-019-00612-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-019-00612-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-019-00612-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T20:05:34Z","timestamp":1584993934000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-019-00612-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":86,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["612"],"URL":"https:\/\/doi.org\/10.1007\/s10875-019-00612-9","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735399631.793572298","asserted-by":"object"}]},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"15 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}